share_log

OKYO Pharma | 3: Initial statement of beneficial ownership of securities-Chief Executive Officer JACOB GARY S

SEC ·  May 16, 2022 17:44
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more